Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$25.39 - $42.1 $151,781 - $251,673
5,978 Added 68.71%
14,678 $617,000
Q1 2024

May 14, 2024

SELL
$27.44 - $35.56 $393,681 - $510,179
-14,347 Reduced 62.25%
8,700 $255,000
Q4 2023

Feb 09, 2024

SELL
$28.47 - $38.49 $101,808 - $137,640
-3,576 Reduced 13.43%
23,047 $837,000
Q3 2023

Nov 13, 2023

SELL
$28.28 - $38.36 $477,027 - $647,056
-16,868 Reduced 38.79%
26,623 $854,000
Q2 2023

Aug 11, 2023

BUY
$17.67 - $31.31 $323,502 - $573,223
18,308 Added 72.7%
43,491 $1.36 Million
Q1 2023

May 15, 2023

BUY
$17.13 - $38.52 $431,384 - $970,049
25,183 New
25,183 $573,000
Q4 2020

Feb 11, 2021

SELL
$35.18 - $43.52 $192,364 - $237,967
-5,468 Closed
0 $0
Q3 2020

Nov 06, 2020

BUY
$37.98 - $48.72 $207,674 - $266,400
5,468 New
5,468 $213,000
Q1 2020

May 08, 2020

SELL
$22.46 - $42.24 $122,227 - $229,870
-5,442 Closed
0 $0
Q4 2019

Feb 12, 2020

BUY
$39.01 - $47.51 $212,292 - $258,549
5,442 New
5,442 $225,000
Q1 2018

May 03, 2018

SELL
$27.0 - $38.5 $222,669 - $317,509
-8,247 Closed
0 $0
Q4 2017

Feb 09, 2018

BUY
$28.0 - $33.2 $230,916 - $273,800
8,247
8,247 $231,000

Others Institutions Holding SRDX

About SURMODICS INC


  • Ticker SRDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 14,005,000
  • Market Cap $477M
  • Description
  • Surmodics, Inc., together with its subsidiaries, provides surface modification technologies for intravascular medical devices, and chemical components for in vitro diagnostic immunoassay tests and microarrays in the United States and internationally. It operates in two segments, Medical Device and In Vitro Diagnostics (IVD). The Medical Device s...
More about SRDX
Track This Portfolio

Track Trexquant Investment LP Portfolio

Follow Trexquant Investment LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Trexquant Investment LP, based on Form 13F filings with the SEC.

News

Stay updated on Trexquant Investment LP with notifications on news.